Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Experimental RNAi02:15

Experimental RNAi

6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

873
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
873

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

scDeepAPA: a deep learning framework for single-cell alternative polyadenylation identification.

Briefings in bioinformatics·2026
Same author

Direct imaging-based gradient metasurface sensor enabling spectrometer-free ultrasensitive biomolecule detection.

Nature communications·2026
Same author

Dynamic needle tip positioning may improve first-attempt success rate in short-axis radial artery cannulation: A systematic review and meta-analysis of randomized trials.

The Journal of international medical research·2026
Same author

VIRSE: a variational Bayesian framework for RNA structural ensemble inference.

Briefings in bioinformatics·2026
Same author

Point-of-care ultrasound during trauma and critical care transport: a practical, safety-gated review.

Frontiers in public health·2026
Same author

Oxidative aging facilitates biological barrier penetration of polyethylene microplastics, amplifying systemic lipotoxicity in aquatic species.

Particle and fibre toxicology·2026

相关实验视频

Updated: Jun 7, 2025

Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.3K

克拉斯在调节IDO1表达方面起着负面作用.

Xiandong Peng1, Eunji Lee1, Jialu Liang1

  • 1Division of Environmental Medicine, Department of Medicine, Grossman School of Medicine, New York University, 341 East 25th Street, New York, NY 10010, USA.

Translational oncology
|November 17, 2024
PubMed
概括

拉斯信号消极地调节了Indoleamine 2,3-dioxygenase-1 (IDO1) 的表达,同时促进了KRas突变癌症中编程细胞死亡蛋白1联体1 (PD-L1) 的表达. 抑制KRasG12C会增加IDO1,这表明KRas和IDO1联合向癌症治疗.

关键词:
标签: 标签: IDO1 标签: IDO1 标签: IDO1免疫检查站检查站干扰素-r 是一种干扰素.克拉斯克拉斯克拉斯克拉斯Kras在PD-L1中.

更多相关视频

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.7K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.4K

相关实验视频

Last Updated: Jun 7, 2025

Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.3K
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

6.7K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.4K

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 免疫学 免疫学 免疫学

背景情况:

  • 拉斯蛋白质是参与细胞过程的关键信号媒介,突变与癌症和炎症疾病有关.
  • 免疫检查点蛋白 (PD-1/PD-L1) 和IDO1是瘤免疫逃避中的关键参与者.
  • 克拉斯在调节IDO1表达中的作用尚不清楚,与其已知对PD-L1.1的影响不同.

研究的目的:

  • 研究KRas突变癌症中IDO1和PD-L1的差异调节.
  • 阐明KRas信号对IDO1表达的影响.
  • 探索同时针对KRas和IDO1的治疗潜力.

主要方法:

  • 在KRas突变癌细胞系和患者样本中分析IDO1和PD-L1表达.
  • 用特定抑制剂ARS-1620治疗KRasG12C-突变细胞.
  • 对干扰素- (IFN-γ) 诱导IDO1表达在活性KRas.存在的情况下的研究.
  • 评估MAPK途径对KRas抑制诱导的IDO1表达的参与.

主要成果:

  • 在KRas突变癌症中,IDO1和PD-L1的调节不同.
  • 通过ARS-1620抑制KRasG12C增加了IDO1的表达,与H358细胞中的PD-L1水平相反相关.
  • 在具有KRas突变的肺和胰腺管腺癌患者中,IDO1的表达减少.
  • 构成性活跃的KRas减弱了IFN-γ诱导的IDO1表达.
  • 克拉斯抑制诱导的IDO1表达独立于MAPK通路发生.

结论:

  • 克拉斯信号负面调节IDO1表达,正面调节PD-L1表达.
  • 抑制KRas可以恢复IDO1的表达,这表明一种潜在的治疗策略.
  • 同时准KRas和IDO1可能会提高治疗效率,并在KRas突变癌症中克服对免疫检查点阻塞的抵抗力.